Jazz Pharmaceuticals Plc (JAZZ)

119.65
NASDAQ : Health Technology
Prev Close 121.13
Day Low/High 118.26 / 122.11
52 Wk Low/High 113.52 / 165.66
Avg Volume 486.60K
Exchange NASDAQ
Shares Outstanding 56.62M
Market Cap 6.86B
EPS 7.50
P/E Ratio 10.96
Div & Yield N.A. (N.A)

13 Drugs Facing FDA Approval Decisions

Here is the updated list of drugs facing FDA approval decisions.

Exec Buys $7M Worth of Jazz Pharma

Director Patrick Enright buys 838,323 shares.

Stock Offerings: Strategic Hotels & Resorts

Strategic Hotels & Resorts was one of several companies to announce public offerings.

Jazz Pharmaceuticals, Inc. Q1 2010 Earnings Call Transcript

Jazz Pharmaceuticals, Inc. Q1 2010 Earnings Call Transcript

14 Biotech Stocks Facing FDA Approval

News of a drug's approval or rejection from the FDA can rock or kill a biotech stock's price. Here are 14 companies with drugs facing FDA approval decisions in 2010.

Jazz Pharma 3Q Loss Narrows On Xyrem Sales

Jazz Pharmaceuticals' 3rd-quarter loss narrows on sales of sleep disorder drug Xyrem

Spectrum shares fall despite drug approval: BioBuzz

Spectrum shares fall despite drug approval: BioBuzz

Uncertainty over Zevalin's relaunch likely weighing on stock price

Osiris Stem Cell Drug Fails: BioBuzz

Negative results announced from two phase III studies in graft-versus-host-disease

Volume, the Great Deceiver

Classic technical analysis teaches that price and volume are interconnected, but this relationship has become unreliable in recent years.

No. 1 Fidelity Biotech Fund Survives Trials

No. 1 Fidelity Biotech Fund Survives Trials

Fidelity's Advisor Biotechnology fund topped the mutual-fund rankings, catapulted by a quadrupling in the share price of Jazz Pharmaceuticals.

Director Buys $6.9M Worth of Jazz Pharma

Jonathan Moreland, author of InsiderInsights, gives you the lowdown on top stock purchases and sales.

Biotech Calendar: Key Clinical Trial Dates

Biotech Calendar: Key Clinical Trial Dates

Part 3 in our quick-and-dirty guide to upcoming clinical trial dates for drug and biotech companies.

Four Must-See Charts: Biotech Stocks

Four Must-See Charts: Biotech Stocks

These biotech stocks could be setting up to make big moves.

BofA, Boeing, Alcoa, Jazz Pharma Are Big Movers

BofA, Boeing, Alcoa, Jazz Pharma Are Big Movers

BofA, Boeing, Alcoa, Jazz Pharma, Cavalier Homes are among big market movers Monday

Jazz Pharma Says Pain Drug Can Treat Fibromyalgia

Jazz Pharma Says Pain Drug Can Treat Fibromyalgia

Jazz Pharmaceuticals reports positive results for late-stage study on pain-condition drug

Health Winners & Losers: Thermage

The wrinkle-treatment device maker soars after saying it had received an offer from a third party.

Health Winners & Losers: Merck

Genzyme climbs on a Wall Street upgrade.

Monday's Health Winners & Losers

Bird flu vaccine flies into safe territory.

Merrill's Europe 2001 HOLDR Begins Trading

Merrill's Europe 2001 HOLDR Begins Trading

It is Merrill's 15th exchange-traded basket of stocks.

TheStreet Quant Rating: B- (Buy)